Trials / Not Yet Recruiting
Not Yet RecruitingNCT07513649
A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R
An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Bioequivalence of DA-5230 With DA-5230-R in Healthy Adult Volunteers
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A study to evaluate the bioequivalence of DA-5230 compared to DA-5230-R
Detailed description
An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Bioequivalence of DA-5230 With DA-5230-R in Healthy Adult Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-5230 | Test drug |
| DRUG | DA-5230-R | Reference drug |
Timeline
- Start date
- 2026-04-01
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2026-04-07
- Last updated
- 2026-04-07
Source: ClinicalTrials.gov record NCT07513649. Inclusion in this directory is not an endorsement.